219 related articles for article (PubMed ID: 16308495)
1. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasma C-reactive protein level and neointimal hyperplasia volume in patients with zotarolimus-eluting stents. Volumetric analysis by three-dimensional intracoronary ultrasound].
Lasave LI; Abizaid AA; Paiva e Maia J; de Ribamar Costa J; Feres F; Mattos LA; Abizaid AS; Siqueira DA; Tanajura LF; Staico R; Beraldo de Andrade P; Braga SN; Sousa AG; Sousa JE
Rev Esp Cardiol; 2007 Sep; 60(9):923-31. PubMed ID: 17915148
[TBL] [Abstract][Full Text] [Related]
4. Impact of preinterventional arterial remodeling on in-stent neointimal hyperplasia and in-stent restenosis after coronary stent implantation.
Hong YJ; Jeong MH; Hyun DW; Hur SH; Kim KB; Kim W; Lim SY; Lee SH; Hong SN; Kim KH; Yun KH; Kang DG; Lee YS; Park HW; Kim JH; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2005 Apr; 69(4):414-9. PubMed ID: 15791035
[TBL] [Abstract][Full Text] [Related]
5. Relation of soft plaque and elevated preprocedural high-sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting.
Hong YJ; Jeong MH; Lim SY; Lee SR; Hong SN; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
Am J Cardiol; 2006 Aug; 98(3):341-5. PubMed ID: 16860020
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.
Walter DH; Fichtlscherer S; Britten MB; Rosin P; Auch-Schwelk W; Schächinger V; Zeiher AM
J Am Coll Cardiol; 2001 Dec; 38(7):2006-12. PubMed ID: 11738308
[TBL] [Abstract][Full Text] [Related]
7. Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting.
Hong MK; Park SW; Mintz GS; Lee NH; Lee CW; Kim JJ; Park SJ
Am J Cardiol; 2000 Feb; 85(4):441-5. PubMed ID: 10728947
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of an antiallergic drug, pemirolast potassium, on restenosis after stent placement: quantitative coronary angiography and intravascular ultrasound studies.
Ohsawa H; Noike H; Kanai M; Hitsumoto T; Aoyagi K; Sakurai T; Sugiyama Y; Yoshinaga K; Kaku M; Matsumoto J; Iizuka T; Shimizu K; Takahashi M; Tomaru T; Sakuragawa H; Tokuhiro K
J Cardiol; 2003 Jul; 42(1):13-22. PubMed ID: 12892037
[TBL] [Abstract][Full Text] [Related]
9. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
[TBL] [Abstract][Full Text] [Related]
11. Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography.
Goto I; Itoh T; Kimura T; Fusazaki T; Matsui H; Sugawara S; Komuro K; Nakamura M
Circ J; 2011; 75(7):1633-40. PubMed ID: 21628836
[TBL] [Abstract][Full Text] [Related]
12. Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation.
Nakatani D; Ako J; Yamasaki M; Shimohama T; Hasegawa T; Otake H; Waseda K; Tsujino I; Sakurai R; Koo BK; Chang H; Yock PG; Sudhir K; Pierson W; Stone GW; Saito S; Honda Y; Fitzgerald PJ
J Invasive Cardiol; 2009 Dec; 21(12):613-7. PubMed ID: 19966361
[TBL] [Abstract][Full Text] [Related]
13. Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome.
Katayama T; Ueba H; Tsuboi K; Kubo N; Yasu T; Kuroki M; Saito M; Momomura S; Kawakami M
Am Heart J; 2007 May; 153(5):762.e1-7. PubMed ID: 17452150
[TBL] [Abstract][Full Text] [Related]
14. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique.
Hoffmann R; Mintz GS; Mehran R; Kent KM; Pichard AD; Satler LF; Leon MB
Am J Cardiol; 1999 Apr; 83(8):1170-4. PubMed ID: 10215278
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
Meneveau N; Schiele F; Grollier G; Farah B; Lablanche JM; Khalifé K; Machecourt J; Danchin N; Wolf JE; Simpson M; Hak JB; Bassand JP
Eur Heart J; 2000 Nov; 21(21):1767-75. PubMed ID: 11052841
[TBL] [Abstract][Full Text] [Related]
17. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.
Takagi T; Akasaka T; Yamamuro A; Honda Y; Hozumi T; Morioka S; Yoshida K
J Am Coll Cardiol; 2000 Nov; 36(5):1529-35. PubMed ID: 11079654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
